Biopharmaceutical Manufacturing

Predefined Single-Use Production Platforms for Biomanufacturing

The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines and bioconjugates.

Companies can streamline early stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late stage activities using process templates that reduce design costs and increase standardization.

Sartorius Biomanufacturing Platforms

Vaccines

Learn More

Blood and Plasma

Learn More

Bioconjugation

Learn More

Regenerative Medicine

Learn More

Biosimilars

Learn More

Intensified Processing

Learn More

Reduce Time-To-Market & Cost with Single-Use Platforms

Free Webinar: Want to Reduce Time to Clinic for Your Viral Vector?

On December 6, Vaccine Platform Marketing Manager Amélie Boulais will discuss high-throughput solutions for downstream process development.

Register Now

Explore Sartorius

Bioprocess Development Engineering

Learn More

Expert Voice, Publications and Case Studies

Learn More

Sartorius Application Center

Learn More